Ποια είναι η κεφαλαιοποίηση αγοράς για Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Η κεφαλαιοποίηση αγοράς για Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) είναι $88.79M

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) Τιμή και Κεφαλαιοποίηση Αγοράς

Q: Ποια είναι η τιμή για Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Η τιμή για Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) είναι $1.15

Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co., Ltd., established in 1964 and previously known as China Chemical Synthesis Industry Co., Ltd., specializes in the development, production, and distribution of active pharmaceutical ingredients (APIs). The company's market reach includes Taiwan and the United States. Their API portfolio encompasses products designed for immunosuppression, oncology, and cardiovascular conditions, in addition to various peptide compounds. Moreover, they manufacture a wide array of bulk pharmaceutical substances for numerous therapeutic applications, including anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular medications, skeletal muscle relaxants, hypolipidemics, antineoplastics, antihyperlipidemics, and immunosuppressants. Complementing its product offerings, Chunghwa Chemical Synthesis & Biotech delivers bespoke research and development as well as contract manufacturing services to both emerging drug developers and established generic pharmaceutical firms.

Η τιμή για 1762	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$67,752.55 $88.79M	NVDA	$5.211T	+5,869,454.77%
$59,111.84 $88.79M	AAPL	$4.547T	+5,120,891.27%
$54,115.98 $88.79M	GOOG	$4.162T	+4,688,088.68%
$46,709.56 $88.79M	MSFT	$3.593T	+4,046,453.29%
$36,309.65 $88.79M	AMZN	$2.793T	+3,145,486.46%

Η τιμή για 1762

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$67,752.55 $88.79M